MedPath

Peripheral Artery Occlusive Disease (PAOD) in Women Hospitalized for Type 1 Myocardial Infarction in Intensive Cardiology Care

Conditions
PAOD - Peripheral Arterial Occlusive Disease
Registration Number
NCT05149456
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

The cardiovascular risk of women has been the subject of particular interest in recent years, in the world, in particular under the impetus of Cardiology companies, with more and more work focusing on the specificities of these diseases in women as well as differences in terms of management and prognosis with a literature mainly based on American data and which focuses particularly on ischemic heart disease.

The expected results are to have a prevalence of PAOD in an Alsatian cohort, most of the data we currently have from American data, with analysis of the impact of specific and non-specific risk factors in this cohort and their weight in PAOD.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Study of the prevalence of peripheral artery occlusive disease (PAOD)Files analysed retrospectively from January 01, 2021 to Jun 30, 2021 will be examined]
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service des Maladies VASC-HTA-Pharmacologie Clinique - Hôpitaux Universitaires de Strasbourg

🇫🇷

Strasbourg, France

© Copyright 2025. All Rights Reserved by MedPath